Target intelligence / Profile preview

Transmembrane protein 65 (TMEM65)

Target
TMEM65
Molecular classification
Transmembrane protein, Mitochondrial inner membrane protein, Ion channel (recent evidence indicates Na^+/Ca^2+ exchanger function)
01

Overview

Transmembrane protein 65 (TMEM65) is a mitochondrial inner membrane protein essential for maintaining normal mitochondrial function, especially mitochondrial respiratory chain activity[1][2]. TMEM65 is also present in the cardiac intercalated disc and is necessary for proper cardiac conduction by facilitating the localization of key proteins such as connexin 43 and the sodium channel NaV1.5 to the intercalated disc[3][5][7]. In cardiomyocytes, TMEM65 physically interacts with the sodium channel β1 subunit, and its loss leads to altered cardiac conduction, dilated cardiomyopathy, and heart failure[3][5]. Recent functional analyses provide evidence that TMEM65 acts as the mitochondrial Na^+/Ca^2+ exchanger, forming homodimers critical for ion exchange and mitochondrial bioenergetics[6]. In oncology, TMEM65 is frequently amplified and overexpressed in gastric cancer, promoting cell proliferation, invasion, and resistance to apoptosis through activation of the PI3K-Akt-mTOR pathway, and serves as an independent prognostic biomarker[1]. Pathogenic mutations in TMEM65 are linked to severe mitochondrial encephalomyopathy with neurological and cardiac deficits[1]. No approved drugs or inhibitors of TMEM65 are currently known, but its multifaceted roles in mitochondrial function, cardiac physiology, and cancer suggest it may be a potential therapeutic target under investigation.

Other names
TMEM65transmembrane protein 65TMM65_HUMAN
02

Biological functions

Mitochondrial bioenergetics (regulation of respiratory chain activity)Cardiac conduction (affecting cardiac electrophysiology and intercalated disc structure)Regulation of cell proliferation and apoptosis (notably in cancer context)
03

Disease associations

Cardiovascular disease (cardiomyopathy, conduction disorders)Neuromuscular disease (mitochondrial myopathy, encephalomyopathy)Cancer (promotes tumorigenesis in gastric cancer)
04

Safety considerations

Loss of function leads to severe cardiac and neurological phenotypes (e.g., cardiomyopathy, mitochondrial disease)Oncogenic overexpression in cancer indicates potential for tumor progression and poor prognosis
05

Biomarkers

Prognostic biomarker in gastric cancer (overexpression correlates with aggressive progression)

Beyond the preview

Go deeper on Transmembrane protein 65 (TMEM65).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 65 (TMEM65).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call